CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-24 | Ekman Lars Director | Grant or award | +3,300 | 17,745 | ||
| 2022-06-24 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2021-06-24 | Ekman Lars Director | Grant or award | +2,145 | 14,445 | ||
| 2021-06-24 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +4,125 | 4,125 | ||
| 2020-06-26 | Ekman Lars Director | Grant or award | +2,550 | 12,300 | ||
| 2020-06-26 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +4,250 | 4,250 | ||
| 2019-06-11 | Ekman Lars Director | Grant or award | +3,000 | 9,750 | ||
| 2019-06-11 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-06-19 | Ekman Lars Director | Grant or award | +3,000 | 6,750 | ||
| 2018-06-19 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 |
Page 1 of 1 · 10 trades